City

Bethesda (1)

Condition

Anti-Asthmatic Agents (1)

Hematologic Diseases (1)

Hypereosinophilia (1)

Leukocyte Disorders (1)

Respiratory System Agents (1)

Overall Status

Active, not recruiting (1)

Sign in for free

Phase

phase 2/phase 3 (1)

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID) (1)

Collaborator

AstraZeneca (1)

Intervention

benralizumab (1)

placebo (1)

Study Documents

Intervention Type

drug (1)

other (1)

Funder Type

NIH (1)

Study Type

Interventional (1)

respiratory system agents

Showing 1 - 1 of 1

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Respiratory System Agents, Anti-Asthmatic Agents, Hematologic Diseases Trial run by the NIAID (benralizumab, Placebo)

Active, not recruiting

Respiratory System Agents
+4 more

benralizumab
Placebo

Bethesda, Maryland

National Institutes of Health Clinical Center, 9000 Rockville Pi

Jan 20, 2022